Collectively, these findings suggest that EZH2 directly represses PPP2R2B expression through chromatin modification, and small molecule inhibition of EZH2 restored PPP2R2B expression and abolished the residual p70S6K and 4EBP1 activity in breast cancer. This evidence concerns the gene PPP2R2B and breast carcinoma.